Changes in gait function associated with cerebral small vessel disease-related cognitive impairment during dual-task walking: a systematic review and meta-analysis.

J NeurolOct 28, 2026 (epub)
Clinical ResearchNeurologyGeriatricsRadiology (Diagnostic)Open access

Tianqing Li, Xiaoya Liu, Tianyu Meng et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis examined whether dual-task (DT) gait measures distinguish people with cerebral small vessel disease-related cognitive impairment (CSVD-CI) from cognitively unimpaired controls, and compared DT with single-task (ST) assessment. The review included nine studies reporting DT outcomes and eight reporting ST outcomes; four reported both. DT assessment discriminated the groups more effectively than ST assessment. Under DT conditions, CSVD-CI was associated with significantly slower gait speed (p = 0.014), greater stride time variability (p = 0.027), and higher dual-task costs (p < 0.001).

Key findings

  • DT gait assessment discriminated CSVD-CI from cognitively unimpaired controls more effectively than ST assessment.
  • Under DT conditions, gait speed was significantly slower in CSVD-CI (p = 0.014).
  • CSVD-CI was associated with greater stride time variability (p = 0.027) and higher dual-task costs (p < 0.001).
  • Subgroup and sensitivity analyses suggested that CSVD imaging characteristics may contribute to between-study heterogeneity; these findings were exploratory.

Why it matters

Gait assessment under added cognitive demand may reveal cognitive-motor differences that are less evident during ordinary walking. The findings identify gait speed, stride time variability, and dual-task costs as candidate behavioral indicators for further study, while underscoring that their screening and predictive value has not yet been established.

What to keep in mind

The review reports heterogeneity in gait metrics, imaging criteria, and cognitive paradigms. The authors describe imaging-related subgroup findings as exploratory and call for standardized diagnostic and inclusion criteria in future studies.

Source

Published in J Neurol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Clinical ResearchOncology (Medical)

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

This international consensus guideline addresses curative-intent management of de novo metastatic nasopharyngeal carcinoma, a population historically treated with palliative intent.

Lancet OncolOct 29, 2026Read summary
Clinical ResearchHematology

Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2A‑rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial.

This open-label, multicentre, randomised phase 3 trial compared decitabine plus busulfan-cyclophosphamide (DAC-BuCy) with BuCy conditioning before allogeneic HSCT in 130 patients aged 14–65 years with KMT2A-rearranged…

Lancet HaematolOct 30, 2026Read summary
Clinical ResearchPediatrics

Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trial.

PROSpect was an international, two-by-two factorial, phase 3 randomised controlled trial comparing prone with supine positioning and high-frequency oscillatory ventilation (HFOV) with conventional mechanical ventilation…

LancetOct 30, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.